Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43588

CD44 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

CD44 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the CD44 gene, which encodes the hyaluronic acid receptor involved in cell adhesion, migration, and signaling. This product provides a heterogeneous pool of HEK293T cells with disrupted CD44 expression, enabling loss-of-function studies without clonal selection artifacts. HEK293T is a widely used human embryonic kidney epithelial cell line ideal for studying CD44-dependent pathways including PI3K/AKT and MAPK/ERK cascades, with downstream effectors such as AKT, ERK1/2, and ??-catenin. Applications include cancer metastasis research, hyaluronan biology, cell migration assays, and drug target validation using western blotting, flow cytometry, and migration/invasion assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    CD44

    Gene Identifier

    NCBI Gene ID 960

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

CD44 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population specifically designed for the targeted disruption of the CD44 gene. This product provides a heterogeneous pool of HEK293T cells carrying CD44 gene disruptions, enabling loss-of-function studies at the population level while avoiding clonal selection artifacts. The polyclonal format is particularly advantageous for functional assays that require a representative distribution of genetic variants, offering a model system that reflects diverse knockout outcomes.

HEK293T is a human embryonic kidney epithelial cell line immortalized by stable integration of the SV40 large T antigen. These adherent cells are among the most widely used mammalian hosts for recombinant protein expression, lentivirus production, and as a model for kidney epithelial cell physiology. The robust growth characteristics and high transfection efficiency of HEK293T make it an ideal background for CRISPR-mediated gene editing, and the polyclonal knockout pool derived from this line provides a convenient and cost-effective tool for a broad range of biochemical and cell-based assays.

CD44 encodes a transmembrane glycoprotein that functions as the principal receptor for hyaluronic acid, mediating cell adhesion, migration, and intracellular signaling. Ligand engagement triggers downstream cascades including PI3K/AKT and MAPK/ERK, as well as Wnt/??-catenin signaling, thereby regulating cell proliferation and motility. CD44 expression is modulated by upstream factors such as TGF-??, EGF, and TNF-??, and it governs the activity of downstream effectors including AKT, ERK1/2, ??-catenin, MMP-9, and Rho GTPases. Additionally, CD44 interacts with ERM proteins, merlin, and osteopontin to coordinate cytoskeletal dynamics and matrix remodeling. Knockout of CD44 therefore disrupts hyaluronan-mediated signaling, impairing PI3K/AKT and MAPK/ERK pathway activation and attenuating cellular processes linked to adhesion and migration.

In HEK293T cells, CD44 knockout enables detailed investigation of CD44-dependent signaling pathways. The epithelial background supports studies of kidney cell biology, and the high transfectability of HEK293T facilitates transient rescue and reporter assays. This model is relevant for epithelial-mesenchymal transition research, where CD44 isoforms regulate plasticity and invasion. The polyclonal nature reduces clonal bias, ensuring robust phenotypic profiling.

This product supports a broad range of applications, including studies on CD44-mediated signaling, hyaluronan biology, cancer metastasis, cell migration, and drug target validation. Characterization can be performed using western blotting, RT-qPCR, flow cytometry, migration/invasion assays, and hyaluronic acid binding assays. Researchers are invited to contact Ascent Research for additional information or custom services.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)